2022 Antisense And RNAi Therapeutics Market Growth Analysis, Size, Share, Trends

Posted by ramtbrc on February 15th, 2022

Antisense & RNAi Therapeutics Global Market Report 2022 by The Business Research Company is the most comprehensive report available on the market, being wide-ranging both in terms of chronology and geography. It covers the historic period – 2016-2021, and the forecast period – 2022-2026, with additional forecasts for 2026-2031. The report helps gain a truly global perspective as it covers 60 geographies, focusing on major economies in each region – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

TBRC’s market report includes a chapter on the COVID-19 impact on the antisense & RNAi therapeutics industry, which gives valuable insights on supply chain disruptions, logistical challenges, and other economic implications of the virus on the market and how companies can strategize to bounce back from it. With updated market numbers according to the effects of the coronavirus, the report provides the most accurate expected antisense & RNAi therapeutics market growth numbers from 2022-2031.

Request a Sample of the report:

The global antisense & RNAi therapeutics market is expected to grow from .32 billion in 2021 to .42 billion in 2022 at a compound annual growth rate (CAGR) of 8%. The growth in the market is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The antisense and RNAi therapeutics market is expected to reach .14 billion in 2026 at a CAGR of 10.8%.

View more on the report:

The Antisense & RNAi Therapeutics Global Market Report 2022-31 by The Business Research Company evaluates antisense & RNAi therapeutics market size, growth rate, drivers, antisense & RNAi therapeutics industry trends, and major companies.

The antisense & RNAi therapeutics market segments in the report are:
1) By Technology: RNA Interference, Antisense RNA
2) By Route of Administration: Pulmonary Delivery, Intravenous Injections, Intra-Dermal Injections, Intraperitoneal Injections, Topical Delivery, Other Delivery Methods
3) By Indication: Oncology, Cardiovascular Diseases (CVDs), Respiratory Disorders, Neurological Disorders, Infectious Diseases, Others

The table of contents in TBRC’s antisense & RNAi therapeutics market report includes:
1. Executive Summary
2. Antisense And RNAi Therapeutics Market Characteristics
3. Antisense And RNAi Therapeutics Market Trends And Strategies
4. Impact Of COVID-19
5. Antisense And RNAi Therapeutics Market Size And Growth
6. Segmentation
7. Regional And Country Analysis
27. Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis

About The Business Research Company:
The Business Research Company is a market intelligence firm that excels in company, market, and consumer research. Located globally it has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services, chemicals, and technology. It has offices in the UK, the US and India and a network of trained researchers in 20+ countries globally.

Get a quick glimpse of our services here: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Contact Information:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293

Like it? Share it!


About the Author

Joined: July 1st, 2020
Articles Posted: 1,611

More by this author